<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="84073">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02036749</url>
  </required_header>
  <id_info>
    <org_study_id>2013/1293</org_study_id>
    <nct_id>NCT02036749</nct_id>
  </id_info>
  <brief_title>Ultrasound-guided Quadratus Lumborum Block for Postoperative Pain Relief After Cesarean Delivery</brief_title>
  <official_title>Ultrasound-guided Quadratus Lumborum Block for Postoperative Pain Relief After Cesarean Delivery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <authority>Norway:National Committee for Medical and Health Research Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The Quadratus Lumborum (QL) Block is an ultrasound-guided technique described by Rafael
      Blanco in 2007. The nerves to the lower abdominal wall can be anesthetized by injecting
      local anesthetics close to the anterior border of the quadratus lumborum muscle. In our
      randomized, controlled, double-blinded study ultrasound-guided QL-blocks in 20 female
      patients after cesarean delivery will be compared with a placebo control group of 20
      patients to investigate analgesic consumption, pain level, opioid related side effects and
      mobilization.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>morphine consumption</measure>
    <time_frame>48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain level (NRS)</measure>
    <time_frame>48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>time to mobilization</measure>
    <time_frame>48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>quadratus lumborum block (nerve block)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>quadratus lumborum block with ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham block</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>QL block with saline</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>nerve block</intervention_name>
    <description>quadratus lumborum block</description>
    <arm_group_label>quadratus lumborum block (nerve block)</arm_group_label>
    <arm_group_label>sham block</arm_group_label>
    <other_name>quadratus lumborum block</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with cesarean delivery

          -  American Society of Anesthesiologists classification (ASA) &lt; 3

          -  adequate communication skills

          -  Body mass index &lt; 32

        Exclusion Criteria:

          -  ASA &gt; 2

          -  chronic pain

          -  neurological illness/ neuropathy

          -  contraindication against local anesthetics
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anders Krohg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anders Krohg, MD</last_name>
    <phone>23070000</phone>
    <phone_ext>+47</phone_ext>
    <email>akrohg@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0023</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Axel R Sauter, MD, phD</last_name>
      <phone>23070000</phone>
      <phone_ext>+47</phone_ext>
      <email>sauter@start.no</email>
    </contact>
    <investigator>
      <last_name>Axel R Sauter, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kyrre Ullensvang, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eldrid Langesaeter, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leiv Arne Rosseland, MD PhD Prof</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Maria E Bekkenes, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anders Krohg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 28, 2014</lastchanged_date>
  <firstreceived_date>January 13, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Oslo University Hospital</investigator_affiliation>
    <investigator_full_name>Anders Krohg</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
